SCHEMBL13147338

SCHEMBL13147338

COc1ccc(COc2cc(-c3ccc(CO)s3)nc(-c3nc(Cl)cs3)n2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE2A O00408 1/20 0.37
KDM4E B2RXH2 5/20 0.35
POLB P06746 5/20 0.35
MAPT P10636 2/20 0.35
ATM Q13315 1/20 0.35
CYP19A1 P11511 2/20 0.34
NOX1 Q9Y5S8 1/20 0.34
LMNA P02545 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
ADORA1 P30542 1/20 0.33
MEN1 O00255 1/20 0.33
GAA P10253 1/20 0.33
KMT2A Q03164 1/20 0.33
APP P05067 1/20 0.33
RAB9A P51151 4/20 0.33
NPC1 O15118 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11926434 0.86 PDE2A (0.35) PDE2AKDM4EPOLBMAPTATM
SCHEMBL13148388 0.85 CYP19A1 (0.39) PDE2AKDM4EPOLBMAPTATM
SCHEMBL13148387 0.83 NPC1 (0.43) PDE2AKDM4EMAPTCYP19A1LMNA
SCHEMBL13147612 0.82 PDE2A (0.38) PDE2AKDM4EPOLBMAPTATM
SCHEMBL13148391 0.80 PDE2A (0.40) PDE2AKDM4EPOLBMAPTATM
SCHEMBL13147613 0.80 CYP19A1 (0.41) PDE2AKDM4EPOLBMAPTCYP19A1
SCHEMBL13147610 0.79 PDE2A (0.40) PDE2AKDM4EPOLBMAPTATM
SCHEMBL13148392 0.79 BRD4 (0.40) PDE2APOLBLMNACYP1A2CYP3A4
SCHEMBL13147687 0.77 PDE2A (0.39) PDE2AKDM4EPOLBMAPTATM
SCHEMBL13147759 0.77 CSF1R (0.49) PDE2AKDM4ERAB9AALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010118078-A1 MACROCYCLIC SERINE PROTEASE INHIBITORS IDENIX PHARMACEUTICALS, INC. (US) 2010-10-14 WO disclosed